CNPOF - Canopy Rivers Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.4500
+0.0800 (+2.37%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close3.3700
Open3.3864
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.2500 - 3.4900
52 Week Range1.7500 - 7.3016
Volume115,950
Avg. Volume138,167
Market Cap664.822M
Beta (3Y Monthly)N/A
PE Ratio (TTM)13.27
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence
    CNW Group2 days ago

    Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence

    TORONTO , May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada .

  • PR Newswire6 days ago

    Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...

  • Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry
    CNW Group8 days ago

    Canopy Rivers Backs BioLumic - Shines Light on New AgTech for the Medical Cannabis Industry

    TORONTO and PALMERSTON NORTH, New Zealand , May 15, 2019 /CNW/ - BioLumic Ltd. ("BioLumic"), creators of a sustainable ultraviolet (UV) crop yield enhancement system, and Canopy Rivers Inc. ("Canopy Rivers") (RIV.V), (CNPOF) today announced a strategic investment from Canopy Rivers. BioLumic extended the Finistere Ventures-led Series A financing round to include Canopy Rivers' strategic investment of US$1.5 million , closing the oversubscribed round at US$6.7 million . This marks Canopy Rivers' first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology.

  • CNW Group8 days ago

    Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

    Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

  • Canopy Growth announces offtake agreement with PharmHouse
    PR Newswire14 days ago

    Canopy Growth announces offtake agreement with PharmHouse

    SMITHS FALLS, ON, May 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce today that has signed an offtake agreement with PharmHouse Inc. ("PharmHouse"), a 49 per cent-owned joint venture of Canopy Rivers Inc. (RIV.V) (OTC:CNOPOF). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years. Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked diligently since October 2018 to prepare the facility for licensing.  PharmHouse will leverage Canopy Growth's genetics – selected and supplied by the Company – and flower will be returned to the Company to be sold under Canopy Growth's diverse brands and banners.  Under the terms of the new offtake agreement, PharmHouse is committed to producing GMP-certified, high quality cannabis flower within 18 months of its cultivation license and the flower must comply with the Company's high standards for cannabis quality.

  • Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth
    CNW Group14 days ago

    Canopy Rivers Announces Significant Supply Agreement Between PharmHouse and Canopy Growth

    TORONTO , May 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce that its portfolio company PharmHouse Inc. ("PharmHouse") has entered into a second offtake agreement (the "Agreement") with Canopy Growth Corporation ("Canopy Growth") (WEED.TO) (CGC) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse's flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018 .

  • PR Newswire16 days ago

    CannaStocks2019 Q1 Investor Conference to be held on Wednesday May 15th at OTC Markets Group

    NEW YORK , May 6, 2019 /PRNewswire/ --  CannaStocks2019 today announced that its Q1 Investor Conference will be held at the OTC Markets Group offices in New York on May 15 th . Participating companies ...

  • PR Newswire20 days ago

    Canopy Rivers congratulates TerrAscend on receiving its EU GMP certification and new distribution agreement

    TORONTO, May 3, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF) on its announcement yesterday that its facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice ("GMP") certificate in accordance with the rules governing medicinal products in the European Union ("EU"). Only medical cannabis from EU GMP certified facilities, or the equivalent, may be sold in the EU. The regulatory approach has been led by several of the larger EU countries and as such, pharmaceutical grade controls in production were an established requirement from the onset of medical cannabis legalization.

  • ACCESSWIRE2 months ago

    Watch These Four Marijuana Stocks Push Their Limits on Wednesday

    Following Canada's country-wide legalization back in October 2018, the cannabis industry has used the momentum gained from Canada's legislation to demonstrate, on a global scale, the economic benefits of investing in cannabis companies. Leafbuyer Technologies Inc (OTC:LBUY), Acreage Holdings Inc (ACRGF), Canopy Rivers Inc (OTC PINK: CNPOF) (RIV.V), The Yield Growth Corp (OTCQB:BOSQF) represent 4 marijuana stocks leading the industry on Wednesday. In recognition of this growing trend to do one's homework, Leafbuyer has become the authority on cannabis-related information.

  • ACCESSWIRE3 months ago

    4 Marijuana Stocks Gaining Speed On Tuesday (2/19/19)

    Although cannabis remains federally criminalized, if more US states follow in California's footsteps, this may result in an influx of investors looking to the marijuana stock market for opportunities. Nabis Holdings (INNPF) (NAB), INSYS Therapeutics Inc (INSY), CannTrust Holdings Inc (OTC PINK: CNTTF), and Canopy Rivers Inc (OTC PINK: CNPOF) (RIV.V) are four cannabis companies picking up speed on Tuesday. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.

  • ACCESSWIRE3 months ago

    These 4 Marijuana Stocks Are Heating Up

    CORAL GABLES, FL / ACCESSWIRE / February 11, 2019 / Following the recent passing of positive legislation, the marijuana stock market has become a hotbed of conversation. In the past, cannabis was condemned ...

  • ACCESSWIRE3 months ago

    These 4 Marijuana Stocks Are Making Key Moves

    CORAL GABLES, FL / ACCESSWIRE / February 5, 2019 / The future of the marijuana stock market will depend on two key factors: industry experts must continue to work to design and manufacture top-of-the-line products meant to elevate the human experience, and consumers must feel confident that companies in the cannabis industry both understand their needs, and are prepared to meet these needs. ParcelPal Technology Inc (PTNYF) (PKG), HEXO Corp (NYSE American: HEXO), Canopy Rivers Inc (OTC PINK: CNPOF), and Charlotte's Web Holdings Inc (CWBHF) (CWEB.CN) represent four companies determined to innovate towards advancing the cannabis industry into the future. The Company created an on-demand marketplace where consumers can shop for anything from food to cannabis.

  • ACCESSWIRE4 months ago

    Three of the Biggest Beneficiaries of the Cannabis Market Boom

    In fact, analysts at Cowen say U.S. cannabis sales alone could reach $80 billion by 2030 - an increase of $5 billion from earlier estimates, and a 4% compound annual growth rate. Piper Jaffray believes the market for legal cannabis could be worth $15 billion to $50 billion a year, with global sales growing to $250 billion to $500 billion. Corporate America is quickly waking up to the opportunity with alcohol companies taking a stake in cannabis stocks.

  • GlobeNewswire4 months ago

    Cannabis Growth Continues to Drive Technology Innovation for EnviroTechnologies International, Canopy Rivers, Aphria and WeedMD

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on how the cannabis industry continues to force technology innovation as it faces new challenges with the sector’s continuing rapid growth. The cannabis industry has begun to fully affect the beverage, food, medical and pharmaceutical industries but one area cannabis has helped drive forward from inception has been the tech industry. Due to the complexity of the cannabis plant as well as the strict regulations surrounding it, technological innovations have been a “must have” for any cannabis company that hopes to expand and grow.

  • ACCESSWIRE4 months ago

    These 4 Marijuana Stocks May Surge On Friday (1/11/19)

    CORAL GABLES, FL/ ACCESSWIRE / January 11, 2019 / The way people receive health care, including how the medical field continues its integration of medical marijuana, is evolving. The fact of the matter is that more people are beginning to trust medicinal cannabis as a means of treatment for a myriad of ailments, including reducing of inflammation and pain relief. As public opinion surrounding cannabis becomes increasingly more favorable, marijuana stocks may begin to present an appealing opportunity for investors looking into the nascent sector.

  • ACCESSWIRE4 months ago

    These 4 Marijuana Stocks That May Surprise You

    CORAL GABLES, FL / ACCESSWIRE / January 10, 2019 / The end of the year was a large turning point for the marijuana industry , as the year's events were instrumental in cementing the growth of the cannabis ...